Philip J. Johnson
Impact in
- Hepatology top 0.02%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Liver Disease and Transplantation
- Otorhinolaryngology top 0.1%
- Head and Neck Cancer Studies
Papers in
- Hepatology 159
- Hepatocellular Carcinoma Treatment and Prognosis 127
- Hepatitis C virus research 37
- Liver Disease and Transplantation 26
- Co-authors
- Winnie YeoAnthony T.�C. ChanIan G. McFarlanePaul B.S. LaiBenny ZeeFrankie MoTony MokWing Ming Ho
- Journals
- Cancer (21 papers)Journal of Clinical Oncology (20 papers)British Journal of Cancer (19 papers)Journal of Hepatology (14 papers)Journal of Medical Virology (8 papers)
- Partner nations
- United KingdomHong KongChina
In The Last Decade
Philip J. Johnson
309 papers receiving 21.2k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Hepatology 11.8k
- Otorhinolaryngology 1.8k
- Epidemiology 8.6k
- Cancer Research 3.6k
- Oncology 5.9k
Countries citing papers authored by Philip J. Johnson
This map shows the geographic impact of Philip J. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip J. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip J. Johnson more than expected).
Fields of papers citing papers by Philip J. Johnson
This network shows the impact of papers produced by Philip J. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip J. Johnson. The network helps show where Philip J. Johnson may publish in the future.
Co-authors
The 25 scholars most cited alongside Philip J. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 6 | |
| 5 | 2022 | 8 | |
| 6 | 2022 | 14 | |
| 7 | 2021 | 34 | |
| 8 | 2021 | 7 | |
| 9 | 2020 | 22 | |
| 10 | 2020 | 7 | |
| 11 | 2020 | 6 | |
| 12 | Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection Hit paper breakdown → | 2018 | 349 |
| 13 | 2016 | 42 | |
| 14 | 2016 | 43 | |
| 15 | 2015 | 11 | |
| 16 | 2005 | 467 | |
| 17 | 2003 | 79 | |
| 18 | Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. | 2002 | 263 |
| 19 | 1997 | 5 | |
| 20 | 1978 | 111 |
About Philip J. Johnson
Philip J. Johnson is a scholar working on Hepatology, Otorhinolaryngology, Cancer Research, Epidemiology and Oncology, having authored 318 papers that have together received 21.8k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (127 papers), Liver Disease Diagnosis and Treatment (101 papers), Hepatitis B Virus Studies (38 papers), Hepatitis C virus research (37 papers), Viral-associated cancers and disorders (34 papers), Cancer, Lipids, and Metabolism (29 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (27 papers) and Liver Disease and Transplantation (26 papers). The work is most often cited by research in Hepatology (11.8k citations), Otorhinolaryngology (1.8k citations), Epidemiology (8.6k citations), Cancer Research (3.6k citations) and Oncology (5.9k citations). Philip J. Johnson has collaborated with scholars based in United Kingdom, Hong Kong and China. Frequent co-authors include Winnie Yeo, Anthony T.�C. Chan, Ian G. McFarlane, Paul B.S. Lai, Benny Zee, Frankie Mo, Tony Mok, Wing Ming Ho, Thomas W. T. Leung and Yuk Ming Dennis Lo. Their work appears in journals such as Cancer, Journal of Clinical Oncology, British Journal of Cancer, Journal of Hepatology and Journal of Medical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.